Anyone interested in a "spec buy" should look at the plethora of information on the Company's web site. There has been fifteen years of development and trials on the drugs now in trials, or in the case of the new one going there soon. There is reason to believe that the current trials will meet their primary end points. The USA Government FDA would not fund the asthma trial unless the data were compelling. Likewise the animal results for CPn10 are remarkable. They also have results from human trials which indicate success in the primary end point for the Lupus trial (down regulating IL6). This is the least speculative biotech at anything like this price.
IVX Price at posting:
12.5¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)